

BioExogen is a next-generation, cell-free biologic platform derived from autologous growth factors that acts as a natural courier for cellular repair. By utilizing high-purity, patient-specific exosomes instead of living cells, it safely orchestrates tissue restoration, vessel growth, and systemic balance.
While traditional exosome therapies rely on off-the-shelf plant or animal sources, BioExogen delivers a highly personalized, cell-free approach utilizing the patient's own biology.

Uses non-human sources (plants/animals) for an off-the-shelf, generic biological signal with potential immune risks.

Uses 100% autologous (patient-derived), cell-free nanoparticles for a perfectly matched, biologically intelligent signal with near-zero immune risk.
Draw venous blood into two BioExogen tubes. Gently invert 6-8 times to mix.
Let tubes stand upright for 30 minutes undisturbed to initiate the release of growth factors and exosomes.
Centrifugate at 4000 RPM for 10 minutes, then isolate the top plasma layer.
Concentrate and clarify the plasma with a two-stage spin: first spin 500 RPM for 10 minutes, second spin 2000 RPM for 10 minutes.
Aspirate the purified supernatant with a sterile syringe, avoiding any settled material at the bottom.
Pass the plasma through a 0.2-micron sterile filter into a final collection tube.

Patient Derived Purity
100% autologous sourcing eliminates any risk of immune rejection or cross-contamination.

Standardized Processing
Proprietary isolation and concentration protocols deliver consistent, reproducible exosome yields.

Targeted Delivery
Nano-scale vesicles penetrate deeply to access injury and inflammation sites that larger molecules cannot reach.
